Rifampicin-resistant tuberculosis
MONDO:0100479A form of drug-resistant tuberculosis that is resisant to rifampicin with or without resistance to other antitubercular medications.
Also known as: RR-TB, rifampicin-resistant TB
27 clinical trials for this condition and its sub-types, 20 tagged with Rifampicin-resistant tuberculosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New 6-Month drug cocktail aims to tame resistant TB
Disease control Not yet recruitingThis phase 3 trial tests whether a 6-month combination of five drugs (bedaquiline, delamanid, delpazolid, levofloxacin, and pyrazinamide) works as well as standard treatment for rifampicin-resistant tuberculosis in adults and adolescents aged 15 and older in South Africa. The stu…
Phase 3 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope against Drug-Resistant TB: phase II trial launches
Disease control Not yet recruitingThis study tests whether adding acetohydroxamic acid (AHA) to a short-course antibiotic regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo alongside standard drugs. The go…
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New 9-Month pill regimen could tackle Drug-Resistant TB
Disease control Not yet recruitingThis phase 3 trial tests a 9-month, all-oral combination of four drugs (BLMZ) for people aged 12 and older with rifampicin-resistant tuberculosis. The goal is to see if this shorter regimen leads to a cure without the need for injections. Participants take the pills daily or week…
Phase 3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a 6-Month pill combo beat Drug-Resistant TB?
Disease control Not yet recruitingThis study tests whether a 6-month combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin) works as well as the standard longer treatment for drug-resistant tuberculosis. Fifty-two adults in Hubei, China will be randomly assigned to either the short or sta…
Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New 6-Month TB drug combo tested in diabetic patients
Disease control Not yet recruitingThis study tests a 6-month treatment regimen containing pretomanid for people with drug-resistant tuberculosis who also have type 2 diabetes. Researchers will compare how well the treatment works and how safe it is in diabetic patients versus non-diabetic patients. The goal is to…
Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Sputum DNA test aims to outsmart Drug-Resistant TB
Diagnosis Not yet recruitingThis trial tests a new DNA test that reads drug resistance directly from sputum samples in people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if this test helps doctors prescribe at least five effective drugs within 14 days of diagnosis, compared to current…
Sponsor: University of Cape Town • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC